Cointime

Cambrian Biopharma

company

About

Cambrian is a distributed development company building therapeutics to lengthen health span.

  • 11 - 50

Highlights

Total Funding Amount
$160M
Funding Rounds
3
Investors
3
Investments
1

Details

Last Funding Type
Series A
Industries
Biopharma,Biotechnology,Life Science
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.

As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$160M
Cambrian Biopharma has raised a total of $160M in funding over 2 rounds. Their latest funding was raised on Oct 26, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 26, 2021 Series C $100M 2 — — Detail
Feb 9, 2021 Series B $60M 1 — — Detail
Nov 1, 2019 Series A — 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Cambrian Biopharma has made 1 investments. Their most recent investment was on Apr 13, 2021, when Arcellx raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 13, 2021 Arcellx
Series C — Biopharma —

Investors

Number of Lead Investors
Number of Investors
—
3
Cambrian Biopharma is funded by 3 investors. Korify Capital and Kliwla Family Office AG are the most recent investors.
Investor Name Lead Investor Funding Round
Korify Capital — Series C
Kliwla Family Office AG — Series C
NJF Capital — Series A
Cointime
Content
Company